Skip to search.
 TSX Up 0.36% TSX Ventures Up 0.60%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
92.02 Down 0.77(0.83%) Jul 26, 4:00PM EDT
Prev Close:92.79
Open:93.27
Bid:78.00 x 100
Ask:125.00 x 1000
1y Target Est:112.56
Beta:1.57425
Next Earnings Date: 4-Aug-16BMRN Earnings announcement
Day's Range:91.21 - 93.43
52wk Range:62.12 - 148.30
Volume:2,160,802
Avg Vol (3m):1,584,050
Market Cap:14.94B
P/E (ttm):N/A
EPS (ttm):-1.18
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
BMRNDown 0.83%14.94B
FOLDUp 5.67%857.38M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-2.16
Quarterly EPS Est (Jun-16) :-0.51
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-1.70

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback